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Optic atrophy 1 (OPA1) is a dynamin protein that mediates
mitochondrial fusion at the inner membrane. OPA1 is also nec-
essary for maintaining the cristae and thus essential for support-
ing cellular energetics. OPA1 exists as membrane-anchored
long form (L-OPA1) and short form (S-OPA1) that lacks the
transmembrane region and is generated by cleavage of L-OPA1.
Mitochondrial dysfunction and cellular stresses activate the
inner membrane–associated zinc metallopeptidase OMA1 that
cleaves L-OPA1, causing S-OPA1 accumulation. The prevailing
notion has been that L-OPA1 is the functional form, whereas
S-OPA1 is an inactive cleavage product in mammals, and that
stress-induced OPA1 cleavage causes mitochondrial fragmenta-
tion and sensitizes cells to death. However, S-OPA1 contains all
functional domains of dynamin proteins, suggesting that it has
a physiological role. Indeed, we recently demonstrated that
S-OPA1 can maintain cristae and energetics through its GTPase
activity, despite lacking fusion activity. Here, applying oxidant
insult that induces OPA1 cleavage, we show that cells unable to
generate S-OPA1 are more sensitive to this stress under obliga-
tory respiratory conditions, leading to necrotic death. These
findings indicate that L-OPA1 and S-OPA1 differ in maintain-
ing mitochondrial function. Mechanistically, we found that cells
that exclusively express L-OPA1 generate more superoxide and
are more sensitive to Ca2-induced mitochondrial permeability
transition, suggesting that S-OPA1, and not L-OPA1, protects
against cellular stress. Importantly, silencing of OMA1 expres-
sion increased oxidant-induced cell death, indicating that
stress-induced OPA1 cleavage supports cell survival. Our find-
ings suggest that S-OPA1 generation by OPA1 cleavage is a sur-
vival mechanism in stressed cells.
Mitochondria are essential eukaryotic organelles, supporting
energetic needs of cells through oxidative phosphorylation
(OXPHOS).2 Mitochondria are structurally unique, consisting
of multiple compartments including the matrix and the double
membranes, inner and outer membranes (IM and OM) enclos-
ing the matrix. OXPHOS takes place in the cristae that are
structurally continuous with, but functionally distinct from, the
IM. Mitochondrial dynamics is a cell biological feature of mito-
chondria, which regulates shape, number, and location of mito-
chondria in cells. Fission and fusion of mitochondrial mem-
branes are the main processes that change mitochondrial shape
and size. Dynamin-family membrane-remodeling proteins
mediate mitochondrial fission and fusion through GTPase
activities.
The optic atrophy 1 (OPA1) is a dynamin-related GTPase
and has a profound role in mitochondrial energetics. OPA1 is
associated with the IM and plays a dual role in mediating IM
fusion and maintaining cristae structure, which are mechanis-
tically independent of each other (1–6). Mutations of OPA1
decrease mitochondrial function and cause optic neuropathy as
well as other systemic disorders, depending on the severity of
mutation-induced mitochondrial dysfunction (7–10). Human
OPA1 protein is encoded by a single gene consisting of 30
exons. Alternative splicing at the N-terminal exons 4, 4b, and
5b generates eight mRNA variants (v1–v8) (11–14). All eight
precursor proteins contain the mitochondrial transit sequence
at the N terminus followed by the transmembrane (TM)
domain and functional enzymatic domains of dynamin proteins
(GTPase domain, middle domain, and the GTPase-effector
domain) (Fig. 1A). During mitochondrial import, OPA1 be-
comes anchored at the IM, leaving the functional domains of
the protein in the intermembrane space (15). The IM-anchored
OPA1 (“L-OPA1” for long form) can be cleaved downstream of
the TM region, generating TM-free OPA1 (“S-OPA1” for short
soluble form). It has been shown that the IM-associated metal-
loprotease OMA1 and the i-AAA protease Yme1L cleave OPA1
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at two sites, S1 and S2, respectively, to generate five visible
variants, a– e (a and b for L-OPA1; c, d, and e for S-OPA1) after
electrophoretic separation (Fig. 1B, WT) (12, 13, 16–19). The S1
site is in the region encoded by exon 5 that is present in all eight
OPA1 variants. In contrast, the S2 site is in the alternatively
splicing exon 5b that is present in four of the eight variants.
There is likely an additional cleavage site (S3 in Fig. 1A) in the
region encoded by exon 4b. The S3 site is cleaved potentially by
Yme1L to generate the major short form “d” (13, 17, 20, 21). The
four OPA1 variants containing the protein sequence encoded
by exon 4b undergo complete cleavage and thus form S-OPA1
exclusively (Fig. 1 (A and B), OPA1-v5) (13, 16, 17, 21). In the
variants that do not have exon 4b, the extent of cleavage at S1 is
small under normal unstressed conditions, and as a result,
uncleaved L-OPA1 and a small amount of cleaved S-OPA1 are
formed (OPA1-v1 in Fig. 1B). However, in stress conditions,
such as mitochondrial depolarization, heat stress, and treat-
ments with hydrogen peroxide (H2O2), oligomycin, or valino-
mycin, the OMA1 activity is enhanced, resulting in loss of
L-OPA1 and accumulation of S-OPA1 (17–19, 22). In contrast,
Yme1L-mediated OPA1 cleavage at S2 has been suggested to be
associated with an increase of OXPHOS-dependent mitochon-
drial fusion (23).
It was shown that L-OPA1 is fusion-competent, but S-OPA1
is not (5, 12, 13, 24, 25). Therefore, OPA1 cleavage associated
with cellular stress results in mitochondrial fragmentation,
which has been considered causal for mitochondrial dysfunc-
tion and cell death (26 –29). It was shown that double KO cells
of OMA1 and Yme1L contain only L-OPA1 due to no OPA1
cleavage and are able to maintain normal cristae structure and
render apoptotic resistance (20). Conversely, prohibitin 2
(Phb2) KO induces a loss of L-OPA1 and concomitant accumu-
lation of S-OPA1, causing mitochondrial fragmentation and
cristae disruption and rendering apoptotic sensitivity. Expres-
sion of L-OPA1 in Phb2-KO cells repaired these defects,
whereas S-OPA1 did not. These observations indicated that
L-OPA1 alone is sufficient to support fusion, energetics, and
cell survival, whereas S-OPA1 plays no active roles in fusion and
cristae maintenance; hence, OPA1 cleavage is considered det-
rimental to cell survival by generating nonfunctional S-OPA1
(30). However, S-OPA1 generated by cleavage contains all of
the functional domains of dynamin proteins and retains the
GTPase activity (31), suggestive of functional significance.
Indeed, our recent studies, using cells expressing L- or S-OPA1
exclusively, demonstrated directly that S-OPA1, despite its
inability to mediate mitochondrial fusion, is fully competent for
maintaining cristae structure and energetic activity through its
GTPase activity (5), which was supported by another study (25).
Energetic competence of S-OPA1 along with the presence
of all functional domains of dynamin proteins in S-OPA1 raises
a possibility that OPA1 cleavage and S-OPA1 accumulation
may have a physiological role, instead of being detrimental to
cell survival. In the present study, by applying oxidant insult
that increases OPA1 cleavage, we show that the absence of
S-OPA1 markedly increases oxidant-induced cell death under
OXPHOS conditions and that S-OPA1 generation is necessary
for supporting cell survival. Mechanistically, we found that L-
and S-OPA1 have contrasting effects on ROS production and
the sensitivity to mitochondrial permeability transition (MPT).
Our data indicate that L- and S-OPA1 are inherently different
in maintaining mitochondrial function, in which S-OPA1 plays
a protective role under cellular stress by extending cell survival.
Results
S-OPA1 confers better cell survival under oxidant insult in
glucose-free OXPHOS conditions
Oxidant insult by H2O2 treatment was shown to accumulate
S-OPA1 by OPA1 cleavage (20, 22). To test the roles of L- and
S-OPA1 in oxidant insult, we used our mouse embryonic fibro-
blast (MEF) lines selectively expressing L-OPA1, S-OPA1, or
both (Fig. 1, A and B) (5). OPA1-v1 has the regions encoded by
exons 4 and 5 with no 4b and 5b and thus is inefficiently cleaved
at S1 and forms mostly L-OPA1 with a small amount of S-OPA1
(Fig. 1B). OPA1-v1 cells increase the S-OPA1 level upon oxi-
dant insult by enhanced cleavage at S1 (Fig. 1, A–C). OPA1-
v1S1 has a deletion of the S1 site in OPA1-v1, forming
L-OPA1 exclusively (Fig. 1, A–C) and thus is unable to form
S-OPA1 even in oxidant stress conditions. OPA1-v5 has the
regions encoded by exons 4, 4b, and 5 and thus contains the S3
and S1 sites and appears to undergo complete cleavage at S3
(Fig. 1, A and B). Therefore, OPA1-v5 cells express S-OPA1
exclusively regardless of oxidant insult (Fig. 1C).
We established stable cell lines expressing each of the
OPA1 variants (OPA1-v1, OPA1-v1S1, or OPA1-v5) in the
OPA1-KO MEFs and chose one clone for each variant, based on
expression levels that are similar to the overall OPA1 level in
WT cells (Fig. S1A). We treated these cells with H2O2 and
examined cell survival using a trypan blue exclusion assay. We
tested this in both glucose-containing and glucose-free condi-
tions to detect potential latent difference in mitochondrial
function among OPA1 variant cells. Glucose medium was the
basal DMEM plus 25 mM glucose, 1 mM pyruvate, 4 mM gluta-
mine, and 5% FBS. Glucose was omitted in glucose-free
medium that essentially serves as an OXPHOS medium. After
18 h of H2O2 treatment (500 M) in glucose medium, we found
no significant death in all cell lines tested, including OPA1-KO
cells (Fig. 2A), suggesting that sufficient energy by glycolysis
renders cells insensitive to H2O2. Under OXPHOS conditions,
without H2O2 treatment, minimal cell death was observed in
WT, OPA1-v1, -v1S1, and -v5 cells, indicating their similar
OXPHOS capacity, consistent with our previous findings (Fig.
2A) (5). OPA1-KO cells showed an increase of cell death in
OXPHOS medium, indicating defective OXPHOS activity (Fig.
2A). Unlike in glucose media, H2O2 treatment in OXPHOS
conditions revealed a clear difference in cell survival between L-
and S-OPA1 cells. Whereas OPA1-KO cells were most sensitive
to oxidant insult as expected, the OPA1-v1S1 line containing
L-OPA1 exclusively was also sensitive, showing only 20% cell
survival. Most significantly, however, S-OPA1– only cells
(OPA1-v5 cells) consistently showed higher cell survival, to a
similar extent as WT and OPA1-v1 cells in H2O2 treatment
(60 –70%) (Fig. 2A).
We confirmed that the different sensitivity of the OPA1 var-
iant cells to oxidant insult is not an artifactual effect in the
particular clones selected. Incubating three different clones
S-OPA1 protects cells under stress













from each variant in glucose-free media containing 500 M
H2O2 for 24 h caused cell shrinkage and detachment in all three
clones of OPA1-v1S1, whereas the clones from OPA1-v1 and
-v5 were well-attached and showed only a small number of dead
cells (Fig. S1B), indicating that the sensitivity to oxidant insult
in the OXPHOS condition is determined by differential pres-
ence of L- and S-OPA1.
We further examined cell viability by using the well-estab-
lished Alamar Blue assay that measures the extent of living cell
respiration by acting as an electron acceptor (32, 33). After a
16-h incubation in 500 M H2O2 in OXPHOS media, the hourly
measurements of percentage reduction of Alamar Blue showed
slower rates of reduction in OPA1-v1S1 and OPA1-KO cells
compared with WT, OPA1-v1, and OPA1-v5 cells (Fig. 2B).
Figure 1. OPA1 variants used in this study. A, OPA1 protein encoded by all exons is shown at the top. MTS, mitochondrial transit sequence; CC, coiled coil
domain; GTPase, GTPase domain; MID, middle domain; GED, GTPase effector domain; MPP, mitochondrial processing peptidase, S1–S3, proteolytic cleavage
sites. Exons 3–5b are indicated. OPA1-v1 contains the S1 site where partial cleavage occurs, producing a small amount of S-OPA1. OPA1-v1S1 has the deletion
of the S1 site in OPA1-v1, producing L-OPA1 exclusively. OPA1-v5 generates S-OPA1 exclusively because of full cleavage possibly at the S3 site. B, expression
of the OPA1 variants in isolated stable lines. Cell lysates of OPA1-v1, OPA1-v1S1, and OPA1-v5 along with WT and OPA1-KO were immunoblotted with
anti-OPA1 antibody. A separate WT immunoblot is included for clarity of different OPA1 bands (a– e). C, OPA1 cleavage in oxidant insult. Cell lysates of WT and
the OPA1 variant cells treated with 250, 500, and 750 M H2O2 for 16 h in OXPHOS media were immunoblotted for OPA1. WT and OPA1-v1 cells show the
conversion of L-OPA1 to S-OPA1, most notably in 500 and 750 M H2O2.
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The 5-h percentage reduction of Alamar Blue was significantly
lower in OPA1-v1S1 and OPA1-KO cells (Fig. 2C), consistent
with the data from the trypan blue cell death assay. These
observations that S-OPA1– containing cells (WT, OPA1-v1,
and OPA1-v5 cells) survive better than L-OPA1– only cells may
reflect a protective role of S-OPA1 in oxidant insult. Further-
more, the manifestation of this difference in OXPHOS condi-
tions suggests that there may be an inherent difference between
L- and S-OPA1 in maintaining mitochondrial function.
We previously reported that mitochondria in cells exclu-
sively having either L- or S-OPA1 (OPA1-v1S1 and OPA1-v5
cells, respectively) were largely fragmented, although OPA1-
v1S1 cells can elongate mitochondria by stress-induced mito-
chondrial hyperfusion (5). It has been shown that H2O2 treat-
ment induces mitochondrial fragmentation (22). Thus, we
examined mitochondrial morphology in OPA1 variant cells
treated with H2O2 in OXPHOS conditions. In WT-MEFs, 500
M H2O2 treatment increased short and fragmented mitochon-
dria (Fig. S2), consistent with previous reports. In contrast,
no significant changes were observed in OPA1-v1S1 and
OPA1-v5 cells treated with H2O2, which is not surprising as
they intrinsically have short and fragmented mitochondria,
although some increase of short tubular mitochondria (inter-
mediate) was found with 16-h incubation in OPA1-v1S1 cells
(Fig. S2). Cells expressing OPA1-v1 showed a mixture of long,
intermediate, and fragmented mitochondria, which was largely
maintained in H2O2 incubation.
H2O2 treatment in glucose-free OXPHOS conditions induces
necrotic cell death
Positive trypan blue staining suggests possible necrosis by
oxidant insult in OXPHOS conditions. We further tested
whether H2O2-induced cell death also involves apoptosis. We
examined cleavages of caspase-3 and poly(ADP-ribose) poly-
merase-1 (PARP-1). Activated caspase-3 by cleavage is a major
executioner of apoptosis and cleaves PARP-1 (34 –36). Cells
were treated with H2O2 in glucose and glucose-free media. We
also treated cells with a well-known apoptotic inducer, actino-
mycin D (actD) as a positive control for apoptosis. In all cell
lines tested, actD treatment increased the cleavage products of
Figure 2. Cells expressing L-OPA1 exclusively (OPA1-v1S1) are more sensitive to oxidant insult. A, trypan blue assays of cells treated with 500 M H2O2
for 18 h in glucose-containing and glucose-free conditions. OPA1-v1S1 and OPA1-KO cells show a significant increase of cell death with H2O2 treatment in
glucose-free OXPHOS conditions. n  4 for glucose-containing; n  6 –9 for glucose-free; *, p  0.05 versus WT and OPA1-v5 (one-way ANOVA, Turkey’s multiple
comparisons); ****, p  0.0001 versus WT, OPA1-v1, and OPA1-v5 (one-way ANOVA, Turkey’s multiple comparisons). Error bars, S.E. B, Alamar Blue was added
after a 16-h incubation in OXPHOS media containing 500 M H2O2, and the reduction of Alamar Blue was measured every hour for 5 h. n  7. Comparisons
within each time point are as follows. a, p  0.001, WT versus OPA1-v1S1; b, p  0.0349, WT versus OPA1-KO; c, p  0.0007, OPA1-v1 versus KO; d, p  0.0001,
OPA1-v1S1 versus OPA1-v1 and -v5 and OPA1-v5 versus KO; e, p  0.0004, OPA1-v1 versus KO; f, p  0.0001, WT versus OPA1-v1S1 and KO; g, p  0.0003,
OPA1-v1 versus KO; h, p  0.0001, OPA1-v1 versus KO (two-way RM ANOVA, Turkey’s multiple comparisons). C, 5-h accumulated reduction of Alamar Blue after
16-h incubation in OXPHOS media containing 500 M H2O2. ****, p  0.0001 versus WT, OPA1-v1, and OPA1-v5 (one-way ANOVA, Turkey’s multiple
comparisons).
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17 and 89 kDa for caspase-3 and PARP-1, respectively, which
are known to be generated during apoptosis (37) (Fig. 3A). In
contrast to actD, H2O2 treatment induced no significant gen-
eration of the 17- and 89-kDa cleavage products of caspase-3
and PARP-1 in all cell lines, including OPA1-v1S1 and
OPA1-KO cells that show more pronounced cell death (Fig. 2).
These results suggest that H2O2-induced cell death does not
involve apoptosis and is necrotic instead.
Interestingly, we observed that glucose-free conditions
decreased actD-induced caspase-3 cleavage compared with
glucose-containing media. This decreased caspase-3 cleavage
was most prominent in OPA1-KO and OPA1-v1S1 cells, as
well as WT cells to some extent, but was not observed in
OPA1-v1 and OPA1-v5 cells (Fig. 3A, long exposure). The same
trend was observed in the 89-kDa cleavage product of PARP-1.
Apoptotic progression requires ATP (38). It is likely that
OPA1-v1 and -v5 cells are able to produce sufficient ATP in
OXPHOS conditions, allowing apoptotic progression. Despite
decreased caspase-3 cleavage, we observed significant death of
OPA1-KO and OPA1-v1S1 cells by actD treatment in glu-
cose-free conditions (results not shown). It is possible that
OPA1-KO and OPA1-v1S1 cells are unable to produce suffi-
cient ATP in OXPHOS conditions, undergoing necrosis
instead. These observations suggest that OPA1-v1 and -v5 cells
may have better OXPHOS capacity than OPA1-v1S1 cells,
consistent with Alamar Blue data.
In addition, immunoblotting of H2O2-treated OPA1 variant
cells in OXPHOS conditions revealed the loss of cytochrome
c in OPA1-v1S1 and OPA1-KO cells (Fig. 3B). These cells
showed a significant loss of cytochrome c even in 250 M
H2O2. Because Tom20 levels were unchanged, it is likely that
cytochrome c is selectively lost in these cells upon H2O2
treatment in OXPHOS media. The degradation or loss of
cytochrome c from dying cells has been reported in late apo-
ptosis and necrosis with more pronounced loss in necrotic
cells (39 –41). These data further support the higher necrotic
sensitivity of OPA1-v1S1 and OPA1-KO cells to H2O2 in
OXPHOS conditions.
Figure 3. H2O2 in OXPHOS conditions increases necrosis. A, immunoblotting for caspase-3 and PARP-1 of total lysates of OPA1 variant, WT, and OPA1-KO
cells treated with 500 M H2O2 or 5 M actD with and without glucose for 16 h. Apoptotic cleavage of caspase-3 and PARP-1 is evident in actD-treated cells, but
not in H2O2-treated cells. B, immunoblotting of total lysates of OPA1 variant cells for cytochrome c and Tom20 showing a loss of cytochrome c from OPA1-
v1S1 and OPA1-KO cells after 16-h H2O2 treatment in OXPHOS media.
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OPA1-v1S1 cells generate more ROS than OPA1-v5 cells in
glucose-free OXPHOS conditions
We found that the sensitivity of OPA1-v1S1 cells to H2O2 is
revealed only under OXPHOS conditions. Because this H2O2
sensitivity of OPA1-v1S1 cells is similar to that of OPA1-KO
cells (Fig. 2) that have an OXPHOS defect, there may be a latent
decrease of mitochondrial function in OPA1-v1S1 cells,
which was not detected in previous studies (5, 25). It is pos-
sible that, under OXPHOS conditions, decreased mitochon-
drial function in OPA1-v1S1 cells generates and accumu-
lates more ROS over time, rendering increased sensitivity to
oxidant insult. Therefore, we evaluated the ROS levels in
OPA1 variant cells in OXPHOS and glucose media without
H2O2 treatment. ROS levels measured by using the oxidation
of dihydroethidium (DHE) indicate that, at 6 h of incubation,
ROS levels were low in all cell lines in the presence of glucose
(Fig. 4A). OXPHOS conditions increased ROS levels by up to
2-fold after 6-h incubation compared with glucose media.
After 16 h in glucose media, ROS levels remained low. How-
ever, in OXPHOS conditions, drastic increases of ROS were
observed in OPA1-v1S1 and OPA1-KO cells with smaller
increases in the other cell lines (Fig. 4A). Similar observa-
tions were made with MitoSOX, showing ROS increase in
OPA1-v1S1 and OPA1-KO cells in OXPHOS conditions
(Fig. S3). The revelation of ROS increase in OPA1-v1S1
cells under OXPHOS conditions may explain susceptibility
of these cells to H2O2-induced cell death. These observa-
tions further suggest that there is a functional difference
Figure 4. Elevated ROS production in OPA1-v1S1 and OPA1-KO cells in OXPHOS conditions. A, OPA1 variant cells along with WT and OPA1-KO cells were
incubated in glucose-containing (G) or glucose-free OXPHOS (Ox) media, and superoxide levels were evaluated at 6 and 16 h by DHE. n  106 –136 for 6 h; n 
108 –160 for 16 h. *, p  0.05; **, p  0.01; ****, p  0.0001 (one-way ANOVA, Turkey’s multiple comparisons). Error bars, S.E. B and C, mito-TEMPO decreases
H2O2-induced cell death. OPA1-v1S1 (B) and OPA1-KO (C) cells were treated with 500 and 750 M H2O2 in the presence and absence of mito-TEMPO (10 M).
Released extracellular (Ec) LDH levels were evaluated for necrotic death. n  5– 6. *, p  0.05 (Student’s t test with corresponding H2O2 concentrations in
control, unpaired). Error bars, S.E.
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between L- and S-OPA1 in which S-OPA1 may play a pro-
tective role.
Dysfunctional mitochondria increase superoxide produc-
tion. We therefore tested whether mito-TEMPO, a mitochon-
drial superoxide scavenger, decreases H2O2-induced necrotic
cell death in OPA1-v1S1 and OPA1-KO cells. For necrosis
assays, we analyzed extracellular lactate dehydrogenase (LDH)
levels in cells incubated with 500 and 750 M H2O2. We found
that including mito-TEMPO in H2O2 incubation decreases cell
death in both OPA1-v1S1 and OPA1-KO cells (Fig. 4, B and
C). However, the extent of the decrease was modest, suggesting
that increased superoxide production may not be the sole con-
tributor to the increased susceptibility of these cells to oxidant-
induced death.
OPA1-v1S1 cells show an increase of oxidative stress in
OXPHOS conditions
Increased ROS levels in OPA1-v1S1 cells in OXPHOS con-
ditions suggest that these cells are in oxidative stress. A
decrease of cellular GSH/GSSG ratio is a measure for increased
oxidative stress. We tested the GSH/GSSG ratio in OPA1 var-
iant cells in both glucose and OXPHOS media in the presence
and absence of 500 M H2O2. Our data showed that OXPHOS
conditions decreased the GSH/GSSG ratio compared with glu-
cose conditions in all OPA1 variant cells as well as WT and
OPA1-KO cells (Fig. 5, A and B). In OXPHOS conditions,
OPA1-v1S1 and OPA1-KO cells showed the greatest decrease
in the GSH/GSSG ratio (Fig. 5, A and B). The data indicate that
the presence of H2O2 in OXPHOS conditions renders more
pronounced differences in GSH/GSSG ratios among OPA1
variant cells (Fig. 5A). These data indicate that OPA1-v1S1
cells are under increased oxidative stress in OXPHOS condi-
tions, compared with OPA1-v1 and -v5 cells. Immunoblotting
showed that there is no significant difference in the levels of
antioxidant enzymes GSH peroxidase (GPx) and Mn-superox-
ide dismutase (MnSOD) among OPA1 variant cells in both glu-
cose and OXPHOS conditions regardless of the presence of
H2O2 (Fig. 5C). OPA1-KO cells showed a decrease in GPx level
with H2O2 in OXPHOS conditions, presumably due to cell
death.
OPA1-v1S1 cells have lower respiration capacity and ATP
levels than OPA1-v5 cells in oxidant insult under OXPHOS
conditions
Our data demonstrated that H2O2 treatment in OXPHOS
conditions increased cell death, ROS, and oxidative stress in
OPA1-v1S1 cells more prominently, compared with WT,
OPA1-v1, and OPA1-v5 cells, suggesting that respiration of
Figure 5. Increased oxidative stress in OPA1-v1S1 cells in OXPHOS conditions. Total GSH and GSSG were measured in cells treated with 500 M H2O2 in
glucose and OXPHOS media for 16 h. A, OXPHOS conditions decrease GSH/GSSG ratio compared with glucose conditions in all OPA1 variant cells, WT, and
OPA1-KO cells. OPA1-v1S1 and OPA1-KO cells show a greater decrease of GSH/GSSG ratio in OXPHOS conditions, which is more prominent in H2O2 treatment
(bottom panels). B, fold changes of GSH/GSSG ratios showing marked decreases of GSH/GSSG ratios in OXPHOS conditions in all cells tested. Values are
normalized to those of glucose with no H2O2 in respective cell lines. N, no H2O2; H, 500 M H2O2. The data were analyzed by one-way ANOVA with Turkey’s
multiple comparisons. Error bars, S.E. C, immunoblotting for GPx and MnSOD shows no significant difference in all test conditions tested except for GPx in
OPA1-KO cells in OXPHOS conditions.
S-OPA1 protects cells under stress













OPA1-v1S1 cells may be compromised in these conditions.
Indeed, respiration analyses support this notion (Fig. 6, A
and B). We performed respiration analyses after incubating
cells with H2O2 in OXPHOS media for 14 h, in which cells
remained well-spread and attached during the assays. Our
data showed that H2O2 treatment under OXPHOS condi-
tions markedly decreased maximal respiration in OPA1-
v1S1 cells, but not in OPA1-v1, OPA1-v5, and WT cells,
indicating that OPA1-v1S1 cells are deficient in electron
transport activity under these conditions (Fig. 6A).
OPA1-KO cells were respiration-defective as we showed
previously (5). The ratio of state 3u/state 4o, a cellular res-
piration control index, clearly indicates greatly decreased
respiration coupling in OPA1-v1S1 cells after oxidant
insult in OXPHSO conditions (Fig. 6B). Immunoblotting
showed no significant change in the levels of respiratory
complex proteins in OPA1-v1S1 cells regardless of the
presence of glucose and H2O2 (Fig. S4).
Our ATP assays support the respiration data, showing that
OPA1-v1S1 cells have a significantly lower ATP level than
OPA1-v1 and -v5 cells in H2O2 treatment under OXPHOS
conditions (Fig. 6C). OPA1-KO cells had very little ATP in
OXPHOS conditions, as expected. Interestingly, the ATP level
of WT cells treated with H2O2 in OXPHOS condition is similar
to that of OPA1-v1S1 cells, suggesting the involvement of
other factors in cell death under oxidant insult.
Cell death induced by H2O2 in glucose-free OXPHOS conditions
involves MPTs
H2O2 can induce MPT by opening of the permeability tran-
sition pore (PTP) (42, 43), causing mitochondrial dysfunction.
Upon MPT, cellular energy crisis by ATP depletion causes
necrotic cell death, which is the probable event for increased
death of OPA1-v1S1 and OPA1-KO cells by H2O2 under glu-
cose-free conditions. Therefore, we tested the involvement of
MPT in H2O2-induced cell death. Although the identity of PTP
is currently unresolved, cyclophilin D (CypD) is an established
regulator of PTP, and cyclosporine A (CsA) decreases MPT by
inhibiting CypD (44 –46). We tested whether CsA decreases
necrotic death caused by H2O2 in OXPHOS conditions by eval-
uating extracellular LDH levels in cells incubated with 250, 500,
and 750 M H2O2.
Consistent with trypan blue assays, OPA1-v1S1 cells
were more sensitive to H2O2 in all three H2O2 concentra-
tions, showing significantly increased LDH release com-
pared with WT, OPA1-v1, and OPA1-v5 cells (Fig. 7, $, §,
and #). The highest H2O2 concentration (750 M) increased
LDH release in OPA1-v1 and OPA1-v5 cells as well, whereas
250 and 500 M H2O2 did not. Importantly, in the presence
of CsA, the levels of LDH release in OPA1-v1S1 cells were
significantly attenuated in all three H2O2 concentrations.
CsA also decreased LDH release in OPA1-v1 and OPA1-v5
cells treated with 750 M H2O2. These data indicate that
MPT contributes to H2O2-induced necrosis, in which the
MPT may play a larger role in the death of OPA1-v1S1 cells
than in OPA1-v5 cell death.
OPA1-v1S1 cells are more sensitive to Ca2-induced MPT
than OPA1-v5 cells
We found a greater contribution of MPT to H2O2-induced
necrosis in OPA1-v1S1 cells than in OPA1-v5 cells (Fig. 7),
suggesting that L- and S-OPA1 cells may have different sensi-
tivities to MPT. MPT occurs through the mitochondrial Ca2
accumulation. Therefore, we examined the MPT sensitivity of
OPA1 variant cells by evaluating mitochondrial calcium reten-
tion capacity (mCRC). The mCRC was measured in digitonin-
permeabilized cells by repeated additions of Ca2 until mito-
chondria were unable to take up Ca2 (47, 48). Most notably,
we found that OPA1-v5 cells have the highest mCRC value (Fig.
8, A and B). On the other hand, OPA1-v1S1 cells had mCRC
lower than OPA1-v1 and OPA1-v5 cells, whereas OPA1-KO
cells had the lowest mCRC (Fig. 8, A and B). The high and low
MPT sensitivities of OPA1-v1S1 and OPA1-v5 cells, respec-
tively, agree well with the difference in cell survival of L- and
S-OPA1 cells under oxidant insult. These data indicate that the
higher MPT sensitivity of OPA1-v1S1 and OPA1-KO cells
contributes to increased cell death by oxidant insult in
OXPHOS conditions.
ROS can potentiate MPT (42, 43), and our data show that
OPA1-v1S1 and OPA1-KO cells generate more ROS in
OXPHOS conditions than the other cell lines (Fig. 4). Because,
in the mCRC assay, mitochondria are energized with respira-
tory substrates, it is possible that increased ROS production
from OPA1-v1S1 and OPA1-KO mitochondria sensitizes
these cells to Ca2-induced MPT. To test the involvement of
ROS in the increased MPT sensitivity of OPA1-v1S1 and
OPA1-KO cells, we included antioxidants in mCRC assays. We
found that neither mito-TEMPO nor MnTMPyP improved
mCRC of OPA1-v1S1 and OPA1-KO cells (Fig. 8C). Further-
more, directly adding H2O2 to the mCRC assay did not decrease
the MPT sensitivity in OPA1-v1 cells (Fig. 8D). Because the
mCRC assay is mainly Ca2-driven in permeabilized cells, and
thus possibly bypasses ROS generation and its effect, these data
indicate that ROS is not the factor that makes these cells sensi-
tive to MPT. As such, the different MPT sensitivities of OPA1-
v1S1 and OPA1-v5 cells are likely the intrinsic properties
exerted by L- and S-OPA1.
To further test the differential MPT in intact cells, we used
the cobalt-quenching calcein assay. In this assay, intact mito-
chondria retain calcein fluorescence, which is quenched by
cobalt ions upon MPT (49, 50). We examined mitochondrial
calcein fluorescence in OPA1 variant cells treated with 500 M
H2O2 in OXPHOS conditions. We found that OPA1-v5 cells
retained higher mitochondrial calcein fluorescence than other
cells (Fig. S5A), consistent with OPA1-v5 rendering reduced
sensitivity to MPT.
Immunoblotting showed a drastically reduced level of
CypD in OPA1-KO cells compared with WT cells (Fig. S5B).
The OPA1 variant cells also contained lower CypD levels
than WT cells. Interestingly, the CypD levels of OPA1-v5
cells were even lower than those of OPA1-KO, OPA1-v1, and
OPA1-v1S1 cells (Fig. S4B), which may support the
increased mCRC of OPA1-v5 cells. However, OPA1-KO
cells have much lower mCRC than WT cells despite its
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reduced CypD level. It is likely that the CypD level is not the
sole component determining the extent of mCRC. Further
studies are necessary to determine the mechanism of regu-
lating MPT in OPA1 variant cells.
Stress-induced OPA1 cleavage is beneficial for cell survival
under oxidant insult
Our data show that the absence of S-OPA1 (OPA1-v1S1
cells) significantly increases cell death under oxidant insult,
suggesting that S-OPA1 generation may be beneficial for cell
survival under stress conditions. Therefore, we hypothesized
that S-OPA1 generation by OPA1 cleavage in stress conditions
plays a protective role. In stress conditions, OMA1 is activated
and cleaves OPA1 at the S1 site (17–19, 22). OPA1-v1 has the
single cleavage site of S1, and H2O2 treatment increases the
OPA1 cleavage to convert L-OPA1 to S-OPA1 (Fig. 1). To test
our hypothesis, we silenced OMA1 in OPA1-v1 cells and asked
whether preventing OPA1 cleavage increases cell death in oxi-
dant insult. We generated stable cells expressing OMA1-
shRNA in OPA1-v1 cells. Immunoblotting shows that OMA1
silencing in OPA1-v1 cells significantly attenuated OPA1 cleav-
age in H2O2 treatment (Fig. 9, A and B). LDH assays indicate
that OPA1-v1 cells with silenced OMA1 show increased cell
death in H2O2 treatment in OXPHOS conditions (Fig. 9C). Res-
Figure 6. Oxidant insult in OXPHOS conditions decreases respiration capacity of OPA1-v1S1 cells. WT, OPA1-KO, and OPA1 variant cells were treated
with 500 M H2O2 in OXPHOS media for 14 h before respiration analyses. A, OCRs of these cells. Markedly reduced maximal respiration is evident in OPA1-v1S1
cells treated with H2O2. OPA1-KO cells are respiration-deficient. Error bars, S.E. B, cellular respiratory control ratios show no significant difference among the
three OPA1 variant cells without H2O2 treatment. H2O2 treatment significantly decreases respiration coupling in OPA1-v1S1 cells, not in OPA1-v1 and
OPA1-v5 cells. N, no H2O2; H, 500 M H2O2. One-way ANOVA was performed with Turkey’s multiple comparisons. Error bars, S.E. C, ATP assays in glucose and
OXPHOS conditions in the presence and absence of oxidant insult. OPA1-v1S1 cells show a significantly lower ATP level than OPA1-v1 and -v5 cells in H2O2
treatment under OXPHOS conditions. N, no H2O2; H, 500 M H2O2. One-way ANOVA was performed with Turkey’s multiple comparisons. Error bars, S.E.
Figure 7. H2O2-induced cell death in OXPHOS conditions involves MPT. WT and OPA1 variant cells were treated with 250, 500, and 750 M H2O2 in OXPHOS
conditions in the presence and absence of 1 M CsA for 18 h, and cell death was evaluated by LDH assays. CsA treatment decreased cell death most prominently
in OPA1-v1S1 cells. n  4 –9. One-way ANOVA was performed. Error bars, S.E. Note that LDH release of OPA1-KO cells was markedly higher than other cells,
although assay values vary greatly.
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piration analyses show that OMA1 silencing in OPA1-v1 cells
decreased respiration after H2O2 treatment in OXPHOS con-
ditions, indicating decreased mitochondrial function (Fig. 9, D
and E). These data demonstrate that S-OPA1 generation by
OPA1 cleavage is necessary for maintaining mitochondrial
function and supporting cell survival in oxidant insult, provid-
ing evidence for the functional importance of S-OPA1 and its
generation. Contrary to conventional notions, our data indicate
Figure 8. L- and S-OPA1 differentially affect the sensitivity to Ca2-induced MPT. A, mCRC assays by repeated additions of Ca2 to permeabilized
OPA1 variant cells. Ca2 (20 n moles each) was added to permeabilized cells (2.8 million/0.5 ml) every 2 min until no more Ca2 was taken up. B,
calculated mCRC. OPA1-v5 cells have significantly higher mCRC than OPA1-v1S1 cells. n  4 –11. One-way ANOVA was performed with Turkey’s
multiple comparisons. Error bars, S.E. C, ROS is not involved in conferring low mCRC in OPA1-v1S1 and KO cells. mCRC assays were performed with 2.9
million (OPA1- v1S1) and 2.7 million cells (OPA1-KO cells) with and without antioxidants: MnTMPyP (50 M) or mito-TEMPO (20 M). Antioxidants had
no effect on mCRC of these cells. D, the addition of H2O2 does not affect mCRC. Shown is the mCRC assay with OPA1-v1 cells (3.0 million cells) in the
presence and absence of 500 M H2O2.
Figure 9. Silencing OMA1 increases H2O2-induced cell death. A, immunoblots of cell lysate of a stable clone expressing OMA1 shRNA in OPA1-v1 cells.
H2O2-induced OPA1 cleavage is attenuated upon OMA1 knockdown (KD) in OPA1-v1 cells. B, quantification of L- and S-OPA1 bands in immunoblotting
showing the percentage of the total. C, LDH assays for cell death analyses. Decreasing OPA1 cleavage by OMA1 silencing in OPA1-v1 cells increases H2O2-
induced cell death. ***, p  0.00036; **, p  0.0012 (Student’s t test, unpaired). Error bars, S.E. D, OCRs of OPA1-v1 and OMA1-KD/OPA1-v1 cells in OXPHOS
conditions with and without H2O2. Error bars, S.E. E, Cellular respiratory control ratios show significantly lower respiration coupling in OMA1-KD/OPA1-v1 cells
treated with H2O2 in OXPHOS conditions, compared with that of OPA1-v1 cells. *, p  0.0149 (Student’s t test, unpaired). Error bars, S.E.
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that stress-induced OPA1 cleavage has a physiological func-
tion, prolonging cell survival by generating S-OPA1 when cells
face adverse conditions.
Discussion
OPA1 is associated with the IM, where it performs a dual
function, IM fusion and cristae maintenance. OPA1’s role for
cristae maintenance is critical for the OXPHOS activity of cells,
as proper cristae structure is required for functional assembly
of respiratory complexes and supercomplexes (5). OPA1 exists
in cells as a mixture of transmembrane L-OPA1 and soluble
S-OPA1 generated by cleavage of L-OPA1. Mitochondrial and
cellular stresses activate OMA1 to induce L-OPA1 cleavage,
accumulating S-OPA1. Previous studies on differential func-
tions of L- and S-OPA1 demonstrated that L-OPA1 is compe-
tent for mitochondrial fusion, but S-OPA1 is not (5, 12, 13, 24,
25). Regarding OPA1’s role for cristae maintenance, different
experimental approaches resulted in contradictory informa-
tion. The studies using the genetic deletions of proteins that
control OPA1 cleavage (OMA1, Yme1L, and Phb2) concluded
that, similar to the IM fusion function, L-OPA1 is the form that
maintains cristae structure, but not S-OPA1 (20, 30). These
data created the notion that S-OPA1 is a functionally insignif-
icant cleavage product and thus OPA1 cleavage in stress condi-
tions is causal for mitochondrial fragmentation and energetic
deficiency, leading to cell demise (27–29). In contrast, more
recent studies using the cell systems that express L- or S-OPA1
exclusively found that S-OPA1 is also capable of maintaining
cristae structure and thus energetic competency, indistinguish-
able from L-OPA1 (5, 25). In the current study, we were able to
further distinguish the energetic function of L- and S-OPA1, in
which S-OPA1 outperforms L-OPA1 in supporting cell survival
in a stress condition.
The functional difference between L- and S-OPA1 was
revealed by applying oxidant stress only under OXPHOS
condition, where cells expressing L-OPA1 exclusively (and
OPA1-KO cells) showed significantly increased sensitivity to
H2O2-induced cell death, compared with S-OPA1– containing
cells. Adding glucose to the OXPHOS media prevented H2O2-
induced cell death in L-OPA1 (OPA1-v1S1) and OPA1-KO
cells, indicating that OXPHOS potentiates oxidant injury in
these cells. Our data show that OPA1-v1S1 and OPA1-KO
cells generate increased levels of superoxide in OXPHOS con-
ditions, which may contribute to sensitizing these cells to
H2O2-induced cell death. In addition to superoxide, another
contributing factor is the inability of these cells to produce suf-
ficient ATP in OXPHOS conditions. H2O2 causes DNA dam-
age. PARP is a DNA damage sensor and, upon H2O2-mediated
DNA damage, is recruited to the DNA lesions, where it rapidly
activates poly(ADP)ribosylation of itself and other proteins
using NAD as a substrate, causing depletion of NAD,
decreased respiration, and ATP production (51–53). There-
fore, insufficient ATP in OPA1-KO and L-OPA1– only cells in
OXPHOS conditions would result in cellular energy crisis, lead-
ing to necrotic cell death. It is interesting that the ATP level of
WT cells under H2O2 treatment in the OXPHOS condition is
similar to that of OPA1-v1S1 cells. It is likely that increased
ROS and oxidative stress in OPA1-v1S1 cells under these con-
ditions also contribute to increased cell death.
Our data indicate that H2O2-induced cell death in OXPHOS
conditions is mostly necrotic as judged by the lack of apoptotic
cleavage of caspase-3 and PARP-1, in contrast to actD-induced
apoptosis. Furthermore, a loss of cytochrome c in OPA1-v1S1
and OPA1-KO cells also indicates necrotic death (Fig. 3B). In
support of this notion, H2O2 treatments in glucose-free condi-
tions appear to increase the 74-kDa fragment of PARP-1 (most
notable in OPA1-v1), one of the necrotic fragments generated
by cathepsins (Fig. 3A) (37, 54).
Our data suggest that there is an intrinsic difference between
L- and S-OPA1 in maintaining mitochondrial function, and we
found the differential regulation of MPT by L- and S-OPA1.
Considering no involvement of ROS in this differential regula-
tion of MPT (Fig. 8, C and D), it is likely that ROS and MPT are
independent factors that dictate cell death sensitivity in
OXPHOS conditions. These observations also suggest that
OPA1 may be a novel regulator of MPT. Based on our data, L-
and S-OPA1 may play opposite roles in MPT, in which L-OPA1
increases MPT whereas S-OPA1 renders resistance to MPT.
Whereas the normal MPT sensitivity is maintained in WT and
OPA1-v1 cells that have both L- and S-OPA1, the lack of
L-OPA1 in OPA1-v5 cells decreases the MPT sensitivity, and
the lack of S-OPA1 in OPA1-v1S1 cells does the opposite. As
for the mechanism of potential OPA1-mediated regulation of
MPT, an interaction between OPA1 and complex V (ATP syn-
thase) has been reported (4). The c-ring of complex V as well as
the dimeric form of complex V were suggested to function as
the PTP (55, 56). It is possible that the OPA1-complex V inter-
action may regulate MPT. However, gene KO studies have dis-
proved the PTP role of complex V (57, 58). Therefore, the
mechanism by which OPA1 may regulate MPT is currently not
understood. A previous report suggested that spastic paraplegia
7 (SPG7) is an essential part of the PTP, as the loss of SPG7
greatly increases mCRC, rendering MPT resistance (59). How-
ever, SPG7 likely functions as a regulator of PTP by modulating
mitochondrial Ca2 (60, 61). SPG7 is a subunit of IM-associ-
ated m-AAA protease that forms heteromeric complex with
another m-AAA subunit, AFG3L2 (62). Interestingly, a previ-
ous report suggested an involvement of SPG7 in OPA1 cleavage
(12). More recently, m-AAA was suggested to regulate OMA1
maturation, contributing to OPA1 cleavage (63). It is possible
that SPG7/m-AAA regulates MPT by controlling OPA1 cleav-
age. Regardless, our data show that L- and S-OPA1 exert oppo-
site effects on MPT sensitivity, which is likely the underlying
mechanism by which L- and S-OPA1 cells have different sus-
ceptibilities to oxidant insult.
The current study provides new information regarding the
functional difference in L- and S-OPA1. We uncovered the dif-
ferences between L- and S-OPA1 in mitochondrial electron
transport activity and in conferring MPT sensitivity. For both,
S-OPA1 is protective in oxidant insult, whereas L-OPA1 alone
without S-OPA1 renders the opposite effect. Furthermore, we
showed that silencing OMA1 in oxidant stress increases cell
death, indicating that S-OPA1 generation by OMA1-mediated
OPA1 cleavage has a protective role. These new findings chal-
lenge the conventional idea that stress-induced OPA1 cleavage
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is detrimental, causing mitochondrial fragmentation and cell
death (26 –29). The literature indicates that OMA1 KO causes
obesity and energetic defect (64), supporting our findings. In
contrast, OMA1-KO mice were protected from heart failure
and renal ischemia (26, 65). OMA1 KO can have a pleiotropic
effect on multiple cellular processes (66 –69); therefore, it
would be difficult to interpret whole-organ/animal physio-pa-
thology by OMA1 KO in relation to OPA1 cleavage. Further-
more, our data using OMA1 silencing were obtained using oxi-
dant insults and simple MEF cells that express only one OPA1
variant (OPA1-v1); therefore, it is possible that they may not
represent the in vivo effect of OMA1 KO on complex patholog-
ical processes of heart failure and renal ischemia.
Regardless of OMA1, our studies using cells exclusively
expressing L- or S-OPA1 demonstrated a beneficial role of
S-OPA1, not L-OPA1, in cellular stress. However, there are
reports that appear to contradict our findings. One study
reported that overexpression of a noncleavable form of OPA1
(similar to the v1S1) was protective against retinal ischemia/
reperfusion injury (70). However, the conclusion is debatable
because, upon insult, there was a greater increase of S-OPA1 in
the retina with the L-OPA1 construct used in the study.
Another study showed that OMA1/Yme1L double-KO cells
that contain only L-OPA1 are resistant to apoptosis induced by
1.0 mM H2O2 (20). Although these data seem to contradict our
observation, the study used glucose-containing media in which
we did not see much cell death. As discussed above, it also
cannot be ruled out that KOs of OMA1 and Yme1L have other
effects in addition to deficiency in generating S-OPA1. Regard-
ing OPA1 and MPT, one study showed that cardiac mitochon-
dria from OPA1/ heterozygous mice had decreased MPT
sensitivity to Ca2 (71). The authors interpreted that this seem-
ingly unexpected result was possibly due to larger mitochondria
in the heart or disorganized IM that perturbs IM-OM associa-
tion that might be necessary for MPT. Whereas our study did
not assess the effect of partial decrease of OPA1, we showed
that OPA1 KO greatly decreased mCRC, which is consistent
with a previous study with OPA1 silencing (72).
Our new notion that S-OPA1 generation is protective can
now explain puzzling results from previous studies with mouse
retinas of hyperhomocysteinemia (HHcy). HHcy induces exci-
totoxicity and oxidative stress in retinal ganglion cells (RGCs).
HHcy mice showed early death of RGCs, but subsequently the
RGC death was attenuated (73), suggesting an activation of a
cellular protective mechanism. Intriguingly, despite the occur-
rence of RGC death in HHcy, the retinal microarray of these
mice and additional analyses showed an increase of OPA1 gene
expression with a more pronounced increase of S-OPA1 vari-
ants (OPA1-v5 and -v8) (73, 74). Gene expression is a costly
task, especially for stressed cells. If S-OPA1 is nonfunctional,
increasing S-OPA1 expression would be a futile effort for cells
under stress. Based on our new findings, it is likely that, in
retinal HHcy stress, increased S-OPA1 expression supports
RGC survival, attenuating cell death and vision loss. Not only in
oxidant insult, our experiments also showed that S-OPA1-con-
taining cells survive better than L-OPA1– only cells in nutrient
depletion (results not shown). Therefore, contrary to the con-
ventional notion that OPA1 cleavage occurring in stress condi-
tions is detrimental, our new data suggest that stress-induced
OPA1 cleavage is a novel protective mechanism in which the




OPA1-KO MEFs were from the American Type Culture Col-
lection (ATCC CRL2995). Stable cell lines expressing each of
the human OPA1 variants (OPA1-v1, OPA1-v1S1, or OPA1-
v5) in the OPA1-KO MEFs were established by puromycin
selection and single-colony isolation as described before (5).
All cell lines were maintained in the complete medium
DMEM (Gibco, 11065-065) supplemented with 10% fetal
bovine serum (FBS), 100 units/ml penicillin, and 100 g/ml
streptomycin. Puromycin (0.5 g/ml) was included except for
WT and OPA1-KO MEFs. For treatment and survival assays,
cells were seeded in the complete medium and then washed
three times with Dulbecco’s PBS (DPBS) and switched to the
test medium: basal DMEM (Sigma–Aldrich, D5030) supple-
mented with 1 mM pyruvate, 4 mM glutamine, 44 mM sodium
bicarbonate, 100 units/ml penicillin, 100 g/ml streptomycin,
and 5% FBS, as glucose-free OXPHOS medium. For glucose-
containing medium, glucose (25 mM) was added to glucose-free
medium. For oxidant insult, H2O2 was added up to 750 M to
the test medium.
Trypan blue assay
Cells were seeded in a 24-well plate in the complete medium
and incubated for 16 –24 h. Cells were then washed with DPBS
and further incubated in test medium containing 500 M H2O2
for 18 h. Cells (both floating and adhering) were harvested and
stained using trypan blue (Invitrogen). Total and trypan blue–
positive cells were counted using an automatic cell counter
(Bio-Rad).
Alamar Blue assay
Cells were seeded in a 96-well plate in the complete medium.
After overnight incubation, cells were washed with DPBS and
further incubated in test medium containing 500 M H2O2 (90
l/well) for 16 h. Ten microliters of 10 Alamar Blue stock
solution (0.4 mg/ml in PBS) was added to each well, and absor-
bance was measured at 570 and 600 nm after 1–5 h using
a microplate reader (BioTek Instruments). The percentage
of reduction of Alamar Blue was calculated by a formula
((117,216  A570  80,586  A600)/(155,677  A	600  14,652 
A	570)  100), where 117,216  molar extinction coefficient of
Alamar Blue in the oxidized form at 600 nm; 80,586  molar
extinction coefficient of Alamar Blue in the oxidized form at
570 nm; 14,652  molar extinction coefficient of Alamar Blue
in the reduced form at 600 nm; 155,677  molar extinction
coefficient of Alamar Blue in the reduced form at 570 nm;
A600  absorbance of test wells at 600 nm; A570  absorbance of
test wells at 570 nm; A	600  absorbance of negative control
wells at 600 nm; and A	570  absorbance of negative control
wells at 570 nm (33).
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The level of ROS was detected using the fluorescent probe
DHE or MitoSOX (Invitrogen). Cells were loaded with 5 M
DHE or MitoSOX in the test medium without FBS and with or
without 25 mM glucose at 37 °C for 30 min. The medium was
removed, and fresh test medium containing 5% FBS was added.
Images were acquired at room temperature, and mean fluores-
cence intensity was measured using IPLab imaging software
(Scanalytics, Inc.).
LDH-based cytotoxicity assay
Released LDH activity, a surrogate marker of necrosis, was
measured using the LDH-Cytotoxicity Assay Kit II (Abcam)
according to the manufacturer’s instructions. At 30 min at
room temperature, final absorbance was measured at 450 nm
(reference at 650 nm) using a microplate reader (BioTek
Instruments).
GSH assay
Cells grown in complete media were washed and incubated
in test media with and without 500 M H2O2 for 16 h, and total
GSH and oxidized GSH (GSSG) was measured using a GSH
colorimetric detection kit (Invitrogen) with modifications (75).
Cells were washed once with prechilled PBS, scraped in PBS on
ice, and pelleted by centrifugation at 1000  g for 5 min at 4 °C.
Pellets were resuspended in ice-cold extraction buffer contain-
ing 0.1% Triton X-100 and 0.6% 5-sulfo-salicylic acid, homog-
enized by sonication, and then frozen at 80 °C. Thawed sam-
ples were centrifuged at 3000  g for 4 min at 4 °C, and
supernatant was subjected to determination of total GSH and
GSSG according to the manufacturer’s protocol. Free glutathi-
one (GSH) concentration was calculated by subtraction of
GSSG (1 GSSG  2 GSH) from total GSH.
Respiration analyses
Oxygen consumption rates (OCRs) were measured using a
Seahorse XFe24 Analyzer (Agilent) according to the manufa-
cturer’s protocol. Briefly, cells were plated into an XFe24 cell
culture microplate in complete media. Cells were then incu-
bated in the test medium with and without 500 M H2O2 for
14 h and further incubated for 1 h in respiration medium
(DMEM with 5 mM pyruvate, 2 mM glutamine, and 5 mM
HEPES without glucose and sodium bicarbonate, pH 7.4) at
37 °C in a non-CO2 incubator. For OCR, 2 M oligomycin, 4 M
carbonyl cyanide p-trifluoromethoxyphenylhydrazone, and 1
M antimycin A and rotenone were injected in sequence. OCR
was normalized by protein amount.
Cellular ATP assay
ATP content was measured using an ATP detection assay
kit-Luminescence (Cayman). Cells incubated in the test
medium with and without 500 M H2O2 for 16 h were washed
once with prechilled PBS and lysed in ATP detection sample
buffer, and ATP concentration was determined according to
the manufacturer’s instructions. ATP levels were normalized
with protein amount.
mCRC analysis
Cells were trypsinized and collected by centrifugation at
156  g for 3 min and resuspended in respiration buffer (125
mM KCl, 2 mM K2HPO4, 1 mM MgCl2, 20 mM HEPES, pH 7.0)
(47). Cells (2 million or more in 0.5 ml) were transferred to the
cuvette and permeabilized by adding digitonin to 0.01%. Mito-
chondria in permeabilized cells were energized by adding 5 mM
glutamate and 2.5 mM malate. Thapsigargin (1 M) was added
to inhibit ER Ca2 uptake. The Ca2 indicator arsenazo III (100
M) was added, and kinetic measurements of absorbance were
performed at 650 nm (reference at 685 nm) (76 –78). After 1
min, 40 M CaCl2 was added at every 2 min until no further
Ca2 uptake was observed. mCRC was calculated by total Ca2
amount taken up per million cells.
Cobalt-quenching calcein assay
Cells were loaded with 1.0 M calcein-acetomethoxy ester
(Invitrogen) and 1.5 mM CoCl2 in DPBS for 15 min at room
temperature. Mitochondrial calcein fluorescence was verified
by MitoTracker Red CMXRos (25 nM, Invitrogen). Calcein fluo-
rescence images were acquired and quantified.
OMA1 silencing
OPA1-v1 cells were infected with lentivirus carrying mouse
OMA1 shRNA (proprietary sequence information, sc-151297-V,
Santa Cruz Biotechnology, Inc.), and stable cells were obtained by
single-colony isolation.
Immunoblot analysis
Protein samples were prepared in Laemmli sample buffer,
run on SDS-polyacrylamide gels, and transferred to the polyvi-
nylidene difluoride membrane. The membranes were blocked,
incubated with primary antibodies overnight at 4 °C, followed
by secondary antibodies, and developed using the chemilumi-
nescence imaging system (Bio-Rad). The following antibodies
were used: anti-OPA1 (612606, BD Biosciences; 1:2000), anti-
caspase-3 (9662, Cell Signaling; 1:1000), anti-PARP-1 (9542,
Cell Signaling; 1:1000), anti-GPx1/2 (sc-133160, Santa Cruz
Biotechnology; 1:1000), anti-MnSOD (611580, BD Biosciences;
1:1000), anti-CypD (18466-1-AP, Proteintech; 1:1000), anti-
NDUFA5 (GTX111016, GeneTex; 1:500) for complex I, anti-
succinate dehydrogenase subunit B (GTX113833, GeneTex;
1:500) for complex II, anti-UQCRC2 (GTX114873, Gene-
Tex; 1:500) for complex III, anti-COX4 (GTX114330, Gene-
Tex; 1:500) for complex IV, anti-ATP synthase subunit  for
complex V (A-21351, Thermo Fisher Scientific; 1:500), anti--
actin (A1978, Sigma; 1:1000), anti-TOM20 (11802-1-AP, Pro-
teintech; 1:1000), anti-OMA1 (sc-515788, Santa Cruz Biotech-
nology; 1:1000), and anti--tubulin (62204, Thermo Scientific;
1:1000). All commercial antibodies have been validated by prior
publications.
Statistical analyses
Quantitative data were analyzed by Student’s t test for the
comparison between two groups (two-tailed, unpaired). For
comparison between multiple groups, analysis of variance
(ANOVA) was used followed by Tukey’s post hoc test. The data
S-OPA1 protects cells under stress













are expressed mostly as means 
 S.E. unless noted otherwise;
p  0.05 was considered a statistically significant difference.
Data availability
All data are contained within the article.
Author contributions—H. L., S. B. S., and Y. Y. conceptualization;
H. L., S. B. S., S.-S. S., and Y. Y. data curation; H. L., S. B. S., and Y. Y.
formal analysis; H. L., S. B. S., S.-S. S., and Y. Y. funding acquisition;
H. L., S. B. S., and Y. Y. validation; H. L., S. B. S., and Y. Y. investiga-
tion; H. L. and S. B. S. methodology; H. L., S. B. S., and Y. Y. writing-
original draft; H. L. and Y. Y. project administration; H. L., S. B. S.,
S.-S. S., and Y. Y. writing-review and editing; S. B. S., S.-S. S., and
Y. Y. resources.
Acknowledgment—We thank David Chan (California Institute of
Technology) for providing OPA1 variant constructs.
References
1. Olichon, A., Baricault, L., Gas, N., Guillou, E., Valette, A., Belenguer, P.,
and Lenaers, G. (2003) Loss of OPA1 perturbates the mitochondrial inner
membrane structure and integrity, leading to cytochrome c release and
apoptosis. J. Biol. Chem. 278, 7743–7746 CrossRef Medline
2. Cipolat, S., Martins de Brito, O., Dal Zilio, B., and Scorrano, L. (2004)
OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc. Natl.
Acad. Sci. U.S.A. 101, 15927–15932 CrossRef Medline
3. Frezza, C., Cipolat, S., Martins de Brito, O., Micaroni, M., Beznoussenko,
G. V., Rudka, T., Bartoli, D., Polishuck, R. S., Danial, N. N., De Strooper, B.,
and Scorrano, L. (2006) OPA1 controls apoptotic cristae remodeling inde-
pendently from mitochondrial fusion. Cell 126, 177–189 CrossRef
Medline
4. Patten, D. A., Wong, J., Khacho, M., Soubannier, V., Mailloux, R. J., Pilon-
Larose, K., MacLaurin, J. G., Park, D. S., McBride, H. M., Trinkle-Mulcahy,
L., Harper, M. E., Germain, M., and Slack, R. S. (2014) OPA1-dependent
cristae modulation is essential for cellular adaptation to metabolic de-
mand. EMBO J. 33, 2676 –2691 CrossRef Medline
5. Lee, H., Smith, S. B., and Yoon, Y. (2017) The short variant of the mito-
chondrial dynamin OPA1 maintains mitochondrial energetics and cristae
structure. J. Biol. Chem. 292, 7115–7130 CrossRef Medline
6. Lee, H., and Yoon, Y. (2018) Mitochondrial membrane dynamics-func-
tional positioning of OPA1. Antioxidants 7, E186 CrossRef Medline
7. Alexander, C., Votruba, M., Pesch, U. E., Thiselton, D. L., Mayer, S.,
Moore, A., Rodriguez, M., Kellner, U., Leo-Kottler, B., Auburger, G., Bhat-
tacharya, S. S., and Wissinger, B. (2000) OPA1, encoding a dynamin-re-
lated GTPase, is mutated in autosomal dominant optic atrophy linked to
chromosome 3q28. Nat. Genet. 26, 211–215 CrossRef Medline
8. Delettre, C., Lenaers, G., Griffoin, J. M., Gigarel, N., Lorenzo, C., Belen-
guer, P., Pelloquin, L., Grosgeorge, J., Turc-Carel, C., Perret, E., Astarie-
Dequeker, C., Lasquellec, L., Arnaud, B., Ducommun, B., Kaplan, J., and
Hamel, C. P. (2000) Nuclear gene OPA1, encoding a mitochondrial dy-
namin-related protein, is mutated in dominant optic atrophy. Nat. Genet.
26, 207–210 CrossRef Medline
9. Amati-Bonneau, P., Valentino, M. L., Reynier, P., Gallardo, M. E., Born-
stein, B., Boissière, A., Campos, Y., Rivera, H., de la Aleja, J. G., Carroccia,
R., Iommarini, L., Labauge, P., Figarella-Branger, D., Marcorelles, P.,
Furby, A., et al. (2008) OPA1 mutations induce mitochondrial DNA in-
stability and optic atrophy “plus” phenotypes. Brain 131, 338 –351
CrossRef Medline
10. Yu-Wai-Man, P., Griffiths, P. G., Gorman, G. S., Lourenco, C. M., Wright,
A. F., Auer-Grumbach, M., Toscano, A., Musumeci, O., Valentino, M. L.,
Caporali, L., Lamperti, C., Tallaksen, C. M., Duffey, P., Miller, J., Whit-
taker, R. G., et al. (2010) Multi-system neurological disease is common in
patients with OPA1 mutations. Brain 133, 771–786 CrossRef Medline
11. Delettre, C., Griffoin, J. M., Kaplan, J., Dollfus, H., Lorenz, B., Faivre, L.,
Lenaers, G., Belenguer, P., and Hamel, C. P. (2001) Mutation spectrum
and splicing variants in the OPA1 gene. Hum. Genet. 109, 584 –591
CrossRef Medline
12. Ishihara, N., Fujita, Y., Oka, T., and Mihara, K. (2006) Regulation of mito-
chondrial morphology through proteolytic cleavage of OPA1. EMBO J. 25,
2966 –2977 CrossRef Medline
13. Song, Z., Chen, H., Fiket, M., Alexander, C., and Chan, D. C. (2007) OPA1
processing controls mitochondrial fusion and is regulated by mRNA splic-
ing, membrane potential, and Yme1L. J. Cell Biol. 178, 749 –755 CrossRef
Medline
14. Landes, T., Leroy, I., Bertholet, A., Diot, A., Khosrobakhsh, F., Daloyau,
M., Davezac, N., Miquel, M. C., Courilleau, D., Guillou, E., Olichon, A.,
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